Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy - Harbeck, N; Alt, U; Berger, U; Krüger, A; Thomssen, C; Jänicke, F; Höfler, H; Kates, R E; Schmitt, M (Clin Cancer Res, 2001)